Cardiovascular Division, Department of Internal Medicine, Hyogo College of Medicine, Hyogo, Japan.
PLoS One. 2018 Jun 18;13(6):e0199263. doi: 10.1371/journal.pone.0199263. eCollection 2018.
Diuretic response is a strong predictor of outcome for admitted patients of acute decompensated heart failure (ADHF). However, little is known about the effects of early diuretic response to carperitide.
We retrospectively analyzed records of 85 patients hospitalized for ADHF who received carperitide as initial treatment and <40 mg furosemide during the early period. The eligible patients were divided into good diuretic responder (GR) group and poor diuretic responder (PR) group on the basis of median urinary volume.
The PR group demonstrated older age, lower body mass index (BMI), lower estimated glomerular filtration rate, and higher blood urea nitrogen (BUN) level, left ventricular ejection fraction, and β-blockers prescribed at baseline than the GR group. The incidence of worsening renal function (WRF) was significantly higher in the PR group than in the GR group. There was no correlation between early intravenous furosemide dose and urinary volume (Spearman correlation, ρ = 0.111, p = 0.312). Multivariate analysis showed that the statistically significant independent factors associated with poor diuretic response to carperitide were BMI (Odds ratio (OR) = 0.82, 95% confidence interval (CI) 0.68-0.94, p = 0.004) and BUN (OR = 1.07, 95%CI 1.01-1.15, p = 0.018). Kaplan-Meier analysis indicated a lower event-free rate in the PR group than in the GR group (log-rank, p = 0.007).
BMI and BUN levels on admission were significant determinants of early poor diuretic response to carperitide. Early poor diuretic response to carperitide was associated with future poor outcomes.
利尿剂反应是急性失代偿性心力衰竭(ADHF)住院患者预后的强有力预测因子。然而,对于卡培利肽早期利尿剂反应的影响知之甚少。
我们回顾性分析了 85 例因 ADHF 住院并在早期接受卡培利肽初始治疗且<40mg 呋塞米的患者记录。根据尿量中位数将合格患者分为良好利尿剂反应(GR)组和不良利尿剂反应(PR)组。
PR 组患者年龄较大,体重指数(BMI)、估计肾小球滤过率(eGFR)较低,血尿素氮(BUN)水平、左心室射血分数(LVEF)较高,且基线时β受体阻滞剂的使用率较高。PR 组肾功能恶化(WRF)的发生率明显高于 GR 组。早期静脉注射呋塞米剂量与尿量之间无相关性(Spearman 相关,ρ=0.111,p=0.312)。多变量分析显示,与卡培利肽不良利尿剂反应相关的独立显著因素是 BMI(比值比(OR)=0.82,95%置信区间(CI)0.68-0.94,p=0.004)和 BUN(OR=1.07,95%CI 1.01-1.15,p=0.018)。Kaplan-Meier 分析表明 PR 组的无事件生存率低于 GR 组(对数秩,p=0.007)。
入院时的 BMI 和 BUN 水平是卡培利肽早期不良利尿剂反应的重要决定因素。卡培利肽早期不良利尿剂反应与未来不良结局相关。